David Lebwohl, EVP, Chief Medical Officer: Intellia Therapeutics NTLA Sell · Filed 01/07

Trade details

Type: Insider sale
Amount: $109,626.63
Shares · price: 11,903 sh · $9.21 a share
Held after: 121,249 sh
Stock: Intellia Therapeutics NTLA
Person: David LebwohlEVP, Chief Medical Officer
Trade date: 26/01/05
Filed: 26/01/07
Days to filing: 2 days

Sold 8.9% of holdings

Share of holding sold: 8.9%

Intellia Therapeutics trades, last 26 weeks

What else happened in Intellia Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/06~02/04

David Lebwohl's recent trades

David LebwohlEVP, Chief Medical Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$116.4K
9,557 sh
$116.4K
Filed 25/01/07
Traded 25/01/03
David LebwohlEVP, Chief Medical Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$172.1K
5,843 sh
$172.1K
Filed 24/01/05
Traded 24/01/03
David LebwohlEVP, Chief Medical Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$95.8K
2,574 sh
$95.8K
Filed 23/01/06
Traded 23/01/04